Overview of Moon Mission Countdown, Trump’s Primetime Speech, New Weight Loss Drug and more
A CNN Podcasts roundup (host: Afalma Dike) covering five key news items for Wednesday, April 1: NASA’s crewed lunar mission countdown, President Trump’s primetime address on the war with Iran, the Supreme Court hearing on birthright citizenship, a scheduling update in the Luigi Mangione murder case, and FDA approval of a second oral GLP-1 weight-loss drug. The episode also includes short promos for CNN’s Chasing Life podcast and the comedy podcast Have I Got News for Your Ears.
Top headlines (quick bullet summary)
- NASA cleared last-minute launch issues for a four-astronaut mission to orbit the moon for 10 days — the first near-moon crewed flight in more than 50 years; the crew will not land.
- Reports say SpaceX filed for a major IPO and allegedly merged with Elon Musk’s AI company XAI earlier this year.
- President Trump will deliver a prime‑time address on the Iran war; he says he wants the conflict ended in 2–3 weeks and has criticized NATO’s support.
- The Supreme Court heard arguments about ending birthright citizenship; a decision is expected by the end of June.
- The FDA approved a second daily oral GLP-1 weight-loss pill (reported name: Foundayo/Fondeo) from Eli Lilly, joining an earlier pill from Novo Nordisk.
Moon mission: what to know
- Mission: Four astronauts launching from Kennedy Space Center for a ~10-day lunar-orbit mission.
- Significance: First crewed mission near the moon in over 50 years; could break Apollo-era distance records and send humans farther from Earth than ever before.
- Limitations: Crew will not land — no lunar-surface capability on this flight.
- Pre-launch issues: NASA resolved a flight-termination system issue and a battery problem just before launch.
- Context: Coverage also notes reporting about SpaceX potentially going public and corporate moves involving Musk’s AI firm.
Trump’s primetime speech and regional developments
- Trump is scheduled to deliver a White House address on the war with Iran — described as his first major national address on the conflict.
- Administration messaging: Trump reportedly will say he wants the war ended within 2–3 weeks and criticizes NATO for insufficient support; reports include Trump saying he is “absolutely considering” removing the U.S. from the alliance.
- On-the-ground violence: Sirens in Tel Aviv after Iran-fired missiles were intercepted; at least 16 people wounded (including an 11-year-old) by missile fragments. Lebanon reported at least 50 people killed in Israeli attacks within a 24-hour window.
Supreme Court – birthright citizenship hearing
- Proceeding: The Supreme Court heard arguments on a Trump administration effort to limit birthright citizenship.
- Notable moment: Chief Justice John Roberts said, “We’re in a new world now. Well, it’s a new world. It’s the same Constitution,” highlighting tensions between modern issues and historical constitutional text.
- Legal angle: Several conservative justices signaled the case might be resolved on narrower statutory or historical grounds without reaching the broad constitutional argument; discussion noted Congress later passed laws echoing the 14th Amendment’s language.
- Attendance: President Trump attended the oral arguments for roughly 75 minutes — the first sitting president to do so — but the read was that his presence did not appear to sway the Court.
- Timeline: A decision is expected by the end of June.
Luigi Mangione federal trial update
- Change: A federal judge delayed Luigi Mangione’s federal trial by one month but denied a request to postpone it until next year.
- New dates: Jury selection now set to begin October 5; opening statements expected October 26 or November 2 (dates could still be revised).
- Charges: Mangione is accused of killing UnitedHealthcare CEO Brian Thompson in 2024; he has pleaded not guilty to federal and state charges and faces life in prison if convicted of the most serious counts.
Health: new oral GLP‑1 weight‑loss drug approved
- FDA action: Approval of a second daily oral GLP-1 weight-loss pill from Eli Lilly (referred to in the transcript as Foundayo / Fondeo).
- Mechanism: Works like other GLP-1 drugs (Ozempic, Wegovy, Zepbound) by mimicking the GLP-1 hormone.
- Compared to earlier pill: This Lilly pill reportedly has dosing advantages — no strict time-of-day or food/water restrictions — unlike the earlier Novo Nordisk pill (referred to as the Wagovi pill) that must be taken upon waking on an empty stomach.
- Market context: Follows the December approval and early‑year rollout of the first oral GLP-1 pill.
Other mentions and promos
- Chasing Life (CNN): Dr. Sanjay Gupta plugs an episode featuring neuroscientist Robert Sapolsky discussing stress and cortisol.
- Have I Got News for Your Ears: Host Michael Ian Black previews an episode featuring Anthony Atamanuik and comedic takes on the war and pop-culture items.
Key dates & takeaways
- NASA lunar mission: imminent launch (no exact launch date in transcript); mission duration ~10 days; no landing.
- Trump address: scheduled for tonight (per transcript) — watch for statements on timeline to end the war and NATO criticisms.
- Supreme Court decision on birthright citizenship: expected by end of June.
- Luigi Mangione federal trial: jury selection Oct 5; opening statements late Oct or early Nov.
- FDA-approved pills: second oral GLP‑1 (Eli Lilly) available with reportedly fewer dosing restrictions than the first oral option.
If you want a one-line summary: NASA is prepping a historic crewed lunar-orbit mission, Trump will deliver a prime-time address on the Iran war, the Supreme Court is weighing limits to birthright citizenship (decision by June), a federal murder trial got new fall dates, and the FDA cleared a second daily oral GLP‑1 weight-loss pill.